Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1

Conditions

Breast Neoplasms 5Polycystic Ovary Syndrome 2Obesity 2Leukemia, Myeloid, Acute 2Head and Neck Neoplasms 2Endometrial Neoplasms 2Triple Negative Breast Neoplasms 1Tracheal Diseases 1TP53 Y220C Mutation 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Sarcoma, Synovial 1Sarcoma, Alveolar Soft Part 1Sarcoma 1Salivary Gland Neoplasms 1Peripheral Nervous System Diseases 1Pancreatic Neoplasms 1Overweight 1Neoplasms 1Neoplasm Metastasis 1Multiple Myeloma 1Motor Activity 1Mesothelioma 1Meningioma 1Medulloblastoma 1Lymphoma 1Lung Neoplasms 1Localized Prostate Cancer 1Leukemia 1Leiomyosarcoma 1

Interventions

pembrolizumab 1enfortumab vedotin 1Thioctic Acid 1Tablets 1Music Therapy 1Lenalidomide 1Gloves, Surgical 1Fish Oils 1Fenofibrate 1Exercise 1Dexamethasone 1Cryotherapy 1Corn Oil 1Bortezomib 1Acupuncture Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Peripheral Nervous System Diseases × Tablets × Clear all
NCT07025005 2025-11-04

VRd MM Fibrate

Tanta University

Phase 4 Recruiting
44 enrolled
Plasma cell

Multiple Myeloma, Neoplasms, Peripheral Nervous System Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡